Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD)
作者： Johanna M.W. van den Berg , Alison M. Morton , Simon W. Kok , Hanno Pijl , Steven P. Conway
DOI: 10.1016/J.JCF.2008.05.008
关键词:
摘要: Abstract Background This study aims to quantitatively and qualitatively assess microvascular complications their risk factors in patients with cystic fibrosis-related diabetes (CFRD) compared those type 1 mellitus (DM1). Methods 79 CFRD were matched DM1 according sex, age duration of insulin therapy. Retinopathy, peripheral neuropathy, nephropathy microalbuminuria the assessed. Risk studied were: smoking, BMI, HbA1c, cholesterol, cholesterol/HDL ratio, diastolic systolic blood pressure. Results Both groups had same number (29%). showed more (21% versus 4.1%; p=0.003), while retinopathy was common (24% 10%; p=0.044). The prevalences neuropathy similar. Patients lower BMI (p Conclusions shown by are similar seen but a prevalence higher microalbuminuria. latter may reflect influence other on renal function.
core.ac.uk
cysticfibrosisjournal.com
elsevier.com参考文章(33)
van Dam Ps, Bakker K, Valk Gd, [Diabetic peripheral neuropathy: international guidelines for prevention, diagnosis, and treatment]. Nederlands Tijdschrift voor Geneeskunde. ,vol. 144, pp. 418- 421 ,(2000)
Antonelli M, Fierimonte S, Pecci G, Stirati G, Fofi C, IgA nephropathy in cystic fibrosis. Journal of Nephrology. ,vol. 12, pp. 30- ,(1999)
Carolyn R. Denning, Margaret M. Sullivan, Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics. ,vol. 84, pp. 642- 647 ,(1989)
D de Zeeuw, P E de Jong, S J L Bakker, R T Gansevoort, [Methods of collecting urine for the determination of microalbuminuria: time for consensus]. Nederlands Tijdschrift voor Geneeskunde. ,vol. 148, pp. 2012- 2015 ,(2004)
Dana S. Hardin, Adrian Leblanc, Gailen Marshall, Dan K. Seilheimer, Mechanisms of insulin resistance in cystic fibrosis American Journal of Physiology-endocrinology and Metabolism. ,vol. 281, ,(2001) , 10.1152/AJPENDO.2001.281.5.E1022
S Lanng, B Thorsteinsson, C Lund-Andersen, J Nerup, PO Schiøtz, C Koch, Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatrica. ,vol. 83, pp. 72- 77 ,(1994) , 10.1111/J.1651-2227.1994.TB12956.X
A. Moran, D. Hardin, D. Rodman, H.F. Allen, R.J. Beall, D. Borowitz, C. Brunzell, P.W. Campbell III, S.E. Chesrown, C. Duchow, R.J. Fink, S.C. Fitzsimmons, N. Hamilton, I. Hirsch, M.S. Howenstine, D.J. Klein, Z. Madhun, P.B. Pencharz, A.L. Quittner, M.K., Robbins, T. Schindler, K. Schissel, S.J. Schwarzenberg, V.A. Stallings, D.E. Tullis, W.B. Zipf, Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Research and Clinical Practice. ,vol. 45, pp. 61- 73 ,(1999) , 10.1016/S0168-8227(99)00058-3
A.J.M. Boulton, F.A. Gries, J.A. Jervell, Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy Diabetic Medicine. ,vol. 15, pp. 508- 514 ,(1998) , 10.1002/(SICI)1096-9136(199806)15:6<508::AID-DIA613>3.0.CO;2-L
Juan F Navarro, Carmen Mora, Manuel Macıéa, Javier Garcıéa, None, Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. American Journal of Kidney Diseases. ,vol. 42, pp. 53- 61 ,(2003) , 10.1016/S0272-6386(03)00408-6
S.E Stephens, S.P.A Rigden, Cystic fibrosis and renal disease. Paediatric Respiratory Reviews. ,vol. 3, pp. 135- 138 ,(2002) , 10.1016/S1526-0550(02)00012-4